Literature DB >> 6448682

A comparison of the efficacy of a live and four inactivated vaccine preparations for the protection of cats against experimental challenge with Chlamydia psittaci.

P E Shewen, R C Povey, M R Wilson.   

Abstract

A commercial live feline-chlamydial vaccine and four experimental inactivated preparations were compared on the basis of clinical protection in cats challenged conjunctivally and intranasally with Chlamydia psittaci. Best protection was afforded by the live vaccine. Good results were also obtained using inactivated preparations of a recent feline conjunctival isolate. Protection did not correlate with the development of complement fixing antibodies but may be related to the induction of a cell mediated response as assessed by the lymphocyte blastogenesis test.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6448682      PMCID: PMC1320069     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  19 in total

1.  SEROLOGICAL STUDIES ON GROUP- AND SPECIES-SPECIFIC ANTIGENS OF TRACHOMA AND INCLUSION CONJUNCTIVITIS (TRIC) AGENTS.

Authors:  A L TERZIN; N A VEDROS; J B JOHNSTON
Journal:  J Hyg (Lond)       Date:  1964-06

2.  Feline pneumonitis. I. Immunization studies in kittens.

Authors:  D G MCKERCHER
Journal:  Am J Vet Res       Date:  1952-10       Impact factor: 1.156

3.  Vaccination against feline pneumonitis.

Authors:  J R Mitzel; A Strating
Journal:  Am J Vet Res       Date:  1977-09       Impact factor: 1.156

4.  Responses of enriched populations of feline T and B lymphocytes to mitogen stimulation.

Authors:  D W Taylor; W A Siddiqui
Journal:  Am J Vet Res       Date:  1977-12       Impact factor: 1.156

Review 5.  Chlamydial infections (second of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-02       Impact factor: 91.245

6.  Immunity to chlamydial infections of the eye. 3. Presence and duration of delayed hypersensitivity to guinea pig inclusion conjuctivitis.

Authors:  R R Watson; A B MacDonald; E S Murray; F Z Modabber
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

7.  Trachoma vaccine studies in monkeys.

Authors:  S P Wang; J T Grayston; E R Alexander
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

8.  The establishment of a specific pathogen free cat (Felis catus) colony.

Authors:  J Bleby; A Lacey
Journal:  J Small Anim Pract       Date:  1969-04       Impact factor: 1.522

9.  Ocular infections in animals with PLT (Bedsonia) group agents.

Authors:  R M Cello
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

10.  Phytomitogen- and antigen-induced blast transformation of feline lymphocytes.

Authors:  G L Cockerell; E A Hoover; A F LoBuglio; D S Yon
Journal:  Am J Vet Res       Date:  1975-10       Impact factor: 1.156

View more
  6 in total

1.  Chlamydophila felis CF0218 is a novel TMH family protein with potential as a diagnostic antigen for diagnosis of C. felis infection.

Authors:  Kenji Ohya; Yu Takahara; Etsuko Kuroda; Saori Koyasu; Shigeyuki Hagiwara; Maki Sakamoto; Mitsuaki Hisaka; Kazuko Morizane; Shinryou Ishiguro; Tsuyoshi Yamaguchi; Hideto Fukushi
Journal:  Clin Vaccine Immunol       Date:  2008-09-03

2.  Effect of vaccination on feline Chlamydia psittaci infection.

Authors:  J M Wills; T J Gruffydd-Jones; S J Richmond; R M Gaskell; F J Bourne
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

3.  Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge.

Authors:  Zonghui Zuo; Yongjuan Zou; Qiang Li; Yongxia Guo; Tianyuan Zhang; Jie Wu; Cheng He; Francis O Eko
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

Review 4.  Chlamydia trachomatis vaccine research through the years.

Authors:  Katelijn Schautteet; Evelien De Clercq; Daisy Vanrompay
Journal:  Infect Dis Obstet Gynecol       Date:  2011-06-26

5.  Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.

Authors:  Stacie J Fairley; Shree R Singh; Abebayehu N Yilma; Alain B Waffo; Praseetha Subbarayan; Saurabh Dixit; Murtada A Taha; Chino D Cambridge; Vida A Dennis
Journal:  Int J Nanomedicine       Date:  2013-05-30

6.  Comparative efficacy of the Leucofeligen™ FeLV/RCP and Purevax™ RCP FeLV vaccines against infection with circulating feline Calicivirus.

Authors:  T Almeras; P Schreiber; S Fournel; V Martin; C S Nicolas; C Fontaine; C Lesbros; S Gueguen
Journal:  BMC Vet Res       Date:  2017-10-10       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.